The lack of alteration of Bax and Bak, taken together with reduction of the levels of antiapoptotic proteins in cancer cells exposed to the VA+UCN-01 combination, would favour a more proapoptotic milieu within treated cells. The gene discussed is BAK1; the disease is cancer.